Medicine · Français

Will NCT05912517 (Janssen Research & Development, LLC) still show a study completion date of 8 October 2029 or earlier when checked on 7 November 2029?

deadline 2029-11-07 confidence medium tier 1 evidence
40%Asturna estimate

Resolution criterion

Yes if, when NCT05912517 is read on clinicaltrials.gov on 7 November 2029, the exact API field protocolSection.statusModule.completionDateStruct.date — Study Completion Date is 8 October 2029 or earlier — that is, the date announced today has not been pushed back. A later recorded date counts as no. If OverallStatus is Terminated, Withdrawn, Suspended, or Unknown status, that counts as no — an unmaintained or halted record is treated as a failure to hold the date, not as a technicality. The value returned by the ClinicalTrials.gov API on the deadline prevails; where the record gives a month without a day, the last day of that month is used. If that exact field is absent or empty on an otherwise existing record, that also counts as no – a missing date is not evidence the deadline will be met, it is treated the same as a halted record.

Verified starting state

As of 8 November 2026: NCT05912517 is registered as RECRUITING, sponsored by Janssen Research & Development, LLC, with 120 participants. Started 2023-12; announced primary completion 2027-08-05, announced study completion 2029-10-08. Record last updated 2026-11-03. The date under test is 2029-10-08. Source: clinicaltrials.gov/study/NCT05912517

What pushes it up

What pushes it down

What would move this number most

Whether participant recruitment and long-term follow-up hit operational bottlenecks over the remaining 3 years before 2029.

How this number is built

Deadline2029-11-07
Base rate36%
Best evidencetier 1 · 1 article(s) used
Independent runs38 · 42 (spread 4 pts)
Confidencemedium
Evidence capnot triggered
Last revised2026-11-08 09:02
Modelgemini-3.8-flash

Sources consulted

ClinicalTrials.gov record NCT05912517 (sponsor: Janssen Research & Development, LLC): overall status RECRUITING; primary completion date 2027-08-05; study completion date 2029-10-08; status last verified by the sponsor 2026-11; record last updated 2026-11-03; enrollment 120 (estimated)tier 1 · ClinicalTrials.gov (U.S. National Library of Medicine) · 2026-11-03